Navigation Links
Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
Date:3/26/2012

International) using the conference ID: NBIX. The call will be archived for three weeks.

About Neurocrine BiosciencesNeurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's VMAT2 program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's VMAT2 program include, but are not limited to; risk that NBI-98854 will not proceed to later stage clinical trials and risk that the Company's clinical trials will fail to demonstrate that NBI-98854 is safe and effective. With respect to its pipeline overall, the Company faces risk that it will be unable to raise additional funding required to complete development of all of its product candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate partners for development, commercial manufacturing and marketing and sales activities for the Company's partnered programs; uncertainties relating to patent protection and intellectual prope
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Neurocrine Biosciences, Inc. Prices Public Offering of Common Stock
2. Neurocrine Biosciences, Inc. Announces Proposed Public Offering of Common Stock
3. Neurocrine Mourns the Passing of Founder and Board Member Wylie Vale, Ph.D.
4. Neurocrine Biosciences to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference
6. Neurocrine Biosciences to Present at the 2011 Credit Suisse Annual Health Care Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2011 Financial Results
8. Neurocrine Biosciences Receives Second Milestone Payment of $20 Million Under Abbott Collaboration Agreement
9. Neurocrine Biosciences Announces Elagolix Scientific Presentations at the 67th Annual Meeting of the American Society for Reproductive Medicine
10. Neurocrine Biosciences to Present at the UBS Global Life Sciences Conference
11. Neurocrine Biosciences Announces the Start of Phase II Study of Elagolix in Uterine Fibroids
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Sept. 22, 2014 China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the ... its 2014 Annual General Meeting of Shareholders (the "AGM") on October ... held at the meeting room of the Company at 6th Floor, ... , Guangdong Province 518054, ...
(Date:9/19/2014)... A pharmaceutical executive in the market research ... he wanted the research and consulting firm to explore: ... for secondary research) to maximize efficiency and maintain a ... , Automation of market research processes for efficient ... to implement and manage those automated systems ...
(Date:9/19/2014)... 19, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market ... industry. The report firstly reviews the basic ... application and manufacturing technology. The report then ... Oxybutynin Hydrochloride listing their product specification, capacity, ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5
... Cosmetic Surgery hopes to raise awareness of some of the ... cosmetic surgery industry through the launch of a series of ... on the subject, such as question and answer sessions, conferences ... new initiatives online, that it hopes people from all over ...
... PINE BROOK, N.J., Oct. 24, 2011 Elusys Therapeutics, ... of antibody therapeutics, announced today that it is initiating ... of Anthim (ETI-204), the company,s anti-toxin in late-stage development ... inhaled anthrax. The company also announced it has successfully ...
Cached Medicine Technology:Liberate Cosmetic Surgery aims to Highlight Cosmetic Surgery Industry Issues 2Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale 2Elusys Initiates Third Clinical Safety Study of Anthim, a New Anthrax Treatment; Company Successfully Completes Manufacturing at Commercial Scale 3
(Date:9/22/2014)... SANTA CLARA, Calif.– Health 2.0 8th ... Healthline , a leading provider of intelligent ... HealthData Engine to harness the power ... and reduce costs. The new big data analytics ... advanced clinical natural language processing (NLP) technologies and ...
(Date:9/22/2014)... 22, 2014 The Advocator Group, LLC— ... its partnership with the RxCut® pharmacy savings program, which ... and employees. The company looks forward to offering prescription ... the ways in which they deliver on the goal ... by Free For All® Inc., the RxCut® ...
(Date:9/22/2014)... Tristar Products, Inc. is celebrating the ... known as the 'Godfather of Fitness,' with the release ... September 24th at the TriBeCa Film Center® in New ... behind the man whose mission was to show the ... The name of the film is derived from one ...
(Date:9/22/2014)... estimated 1.68 to 3.8 million sports-related concussions occur in ... a significant number that go unreported. Current Concepts ... of Neurosurgery , official journal of ... Gail Rosseau, MD, the lead guest editor, is well ... prevention, and serves on the Board of Directors of ...
(Date:9/22/2014)... Research reveals that the body’s supply ... declines during the aging process. This decline allows the ... as wrinkles, droopy skin, weakened muscles and loss of ... Growth Hormone (GH) Secretion and Insulin-Like Growth Factor I ... the aging process. , Decades of scientific research ...
Breaking Medicine News(10 mins):Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 2Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 3Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 4Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 5Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 2Health News:The Advocator Group, LLC Announces Partnership with Pharmacy Savings Program RxCut® 3Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 2Health News:Tristar Products Premieres The Jack LaLanne Documentary at TriBeCa Film Center in New York City 3Health News:Neurosurgery tackles past, current and future concepts of sports concussion 2Health News:Neurosurgery tackles past, current and future concepts of sports concussion 3Health News:Neurosurgery tackles past, current and future concepts of sports concussion 4Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 2Health News:Diet Doc Reveals the Secret to Looking and Feeling Younger with new Prescription Sermorelin hGH Anti-Aging Therapy 3
... New Zealanders and mild deficiency in some parts of ... New Zealand (FSANZ) to consider a proposal to replace ... products. Recent studies had shown that Australians, particularly ... ,The proposal by FSANZ is aimed at reducing iodine ...
... in Cambodia have now been affected by bird flu killing ... after a man smuggled infected ducks in from Vietnam. ... as telling Reuters that two people were admitted to the ... in Prey Veng province around 1,300 ducks died from bird ...
... milestone in the mapping of the bovine genome, which will ... disease// control in cattle. This research is slated to benefit ... up on a sequence of 2.9 million DNA base pairs, ... in one pair, which can alter the productivity of the ...
... paint has been created by scientists at Cornell University ... ,This edible paint made by creating colored calcium alginate ... has a wide range of applications, including food and ... that, although the technology was originally developed for non-food ...
... initial clinical trials show that China’s first AIDS vaccine ... people who received the injections showed no severe adverse ... said Zhang Wei, head of the pharmaceutical registration department ... ,"The recipients appeared immune to the HIV-1 virus ...
... ten years back from a graveyard has led police to believe ... ,The missing of the corpse came to light only ... being hit by lightning, complained that his body had gone missing ... family used to offer prayers on the grave and were shocked ...
Cached Medicine News:Health News:Scientists Develop Non-Toxic, Food Safe Paint 2Health News:China’s AIDS vaccine-successfully finishes first phas 2Health News:Police Stumble into Trading Corpses Racket 2
... Sun Med TruFlow™ Oxygen flowmeter with a ... warranty covering calibration and manufacturing defects. A ... meet most needs. Also available with all ... power take-off and double unit configurations. Our ...
... adults, the entire series of time-tested Timeter® ... the needs of care providers and patients ... accuracy. You can see it in the ... performance, year after year. Every Timeter® Classic ...
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
The Soft-Touch Timeter® Flowmeter is durable, long-lasting and easy to maintain. Timeter ® by Allied Flowmeters: Quality Plus Value....
Medicine Products: